Portfolio Companies 2026 for Qiming Venture Partners USA: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Qiming Venture Partners USA accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $1.5B. The median disclosed raise is $75M, and the largest is Talaris Therapeutics at $365M, ahead of Ventyx Biosciences ($165M) and Korro Bio ($162M).
The names that recur most often on these portfolio cap tables are Qiming Venture Partners USA (14 companies), Surveyor Capital (4 companies), Janus Henderson Investors (4 companies), Cormorant Asset Management (3 companies), venBio Partners (3 companies), Logos Capital (2 companies). By latest disclosed round, the market skews Series A (9), Series C (3), Other Equity (1), Growth (1).
Companies tracked: 14
Disclosed funding total: $1.5B across 14 companies
Median disclosed raise: $75M
Largest raise: Talaris Therapeutics — $365M
Stage mix: Series A 9 · Series C 3 · Other Equity 1 · Growth 1
